Mirena IUD Duration of Use
A single Mirena IUD can be used for up to 8 years for contraception. 1
Evidence-Based Duration
The FDA-approved Mirena (levonorgestrel 52 mg intrauterine system) has demonstrated high contraceptive efficacy extending well beyond its original 5-year approval:
Extended Use Through 8 Years
The Mirena Extension Trial established that the 52 mg levonorgestrel-releasing intrauterine system maintains excellent contraceptive efficacy through 8 years of continuous use, with a 3-year Pearl Index (years 6-8) of 0.28 and a cumulative failure rate of only 0.68% 1
Two pregnancies occurred during years 6-8 of use: one pregnancy of undetermined location in year 6 and one ectopic pregnancy in year 7, both with the device in situ 1
Zero pregnancies occurred in year 8 specifically, demonstrating maintained efficacy 1
Supporting Evidence
The Liletta study (evaluating an identical 52 mg levonorgestrel system) confirmed similar findings with 2 pregnancies in year 7 (Pearl Index 0.49) and no pregnancies in year 8, yielding a cumulative pregnancy rate through 8 years of 1.32% 2
User satisfaction remained exceptionally high, with 98.7% of participants who completed 8 years reporting satisfaction with continued use 1
Safety Profile Through Extended Use
Bleeding patterns improved over time, with approximately 50% of women experiencing amenorrhea or infrequent bleeding during years 6-8 1
Discontinuation rates for bleeding complaints were minimal at only 0.1-0.5% per year during years 3-8 2
Adverse events remained low, with expulsion rates of 4.1% overall and pelvic infection diagnosed in only 0.9% of participants through 8 years 2
Clinical Implications
Patients can be counseled that their Mirena IUD retains contraceptive effectiveness for extended use up to 8 years, reducing the need for replacement procedures 3
The cumulative failure rate for years 6-8 (0.68%) is comparable to reported rates for the first 5 years of use 3
Important Caveat
Ectopic pregnancy risk: Of the 11 total pregnancies occurring over 8 years in the Liletta study, 7 (64%) were ectopic, highlighting the importance of maintaining high clinical suspicion for ectopic pregnancy in any Mirena user who becomes pregnant 2